Exane Derivatives Raytheon Technologies Corp Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Raytheon Technologies Corp stock. As of the latest transaction made, Exane Derivatives holds 28 shares of RTX stock, worth $3,261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 28
-0.0%
Holding current value
$3,261
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RTX
# of Institutions
2,981Shares Held
1.05BCall Options Held
15.6MPut Options Held
11.9M-
Vanguard Group Inc Valley Forge, PA117MShares$13.7 Billion0.26% of portfolio
-
State Street Corp Boston, MA112MShares$13 Billion0.56% of portfolio
-
Black Rock Inc. New York, NY95.8MShares$11.2 Billion0.22% of portfolio
-
Capital Research Global Investors Los Angeles, CA79.5MShares$9.26 Billion2.08% of portfolio
-
Capital International Investors Los Angeles, CA63.7MShares$7.42 Billion1.53% of portfolio
About RAYTHEON TECHNOLOGIES CORP
- Ticker RTX
- Exchange NYSE
- Sector Industrials
- Industry Aerospace & Defense
- Shares Outstandng 1,470,060,032
- Market Cap $171B
- Description
- Raytheon Technologies Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers worldwide. It operates through four segments: Collins Aerospace Systems, Pratt & Whitney, Raytheon Intelligence & Space, and Raytheon Missiles & Defense. The Collins Aerospace Syste...